These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1247198)

  • 61. [Serological response of cattle to the bacterial kind of Moraxella bovis].
    Handl R; Kubes O
    Vet Med (Praha); 1972 Mar; 17(3):167-74. PubMed ID: 4624040
    [No Abstract]   [Full Text] [Related]  

  • 62. Serotypes and antibiotic sensitivity of Moraxella bovis isolated from an outbreak of infectious bovine keratoconjunctivitis.
    Gil-Turnes C; Albuquerque IM
    Can J Comp Med; 1984 Oct; 48(4):428-30. PubMed ID: 6509372
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Moraxella bovis pili vaccine produced by recombinant DNA technology for the prevention of infectious bovine keratoconjunctivitis.
    Lepper AW; Elleman TC; Hoyne PA; Lehrbach PR; Atwell JL; Schwartzkoff CL; Egerton JR; Tennent JM
    Vet Microbiol; 1993 Jul; 36(1-2):175-83. PubMed ID: 7901935
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of vaccination with live or killed Pasteurella haemolytica on resistance to experimental bovine pneumonic pasteurellosis.
    Confer AW; Panciera RJ; Fulton RW; Gentry MJ; Rummage JA
    Am J Vet Res; 1985 Feb; 46(2):342-7. PubMed ID: 3888006
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of face flies in an episode of infectious bovine keratoconjunctivitis.
    Gerhardt RR; Allen JW; Greene WH; Smith PC
    J Am Vet Med Assoc; 1982 Jan; 180(2):156-9. PubMed ID: 7061312
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antigenic characterization of Moraxella bovis, Moraxella bovoculi and Moraxella ovis strains with potential use in vaccines.
    Kowalski AP; Maboni G; Gressler LT; Espíndola JP; Balzan C; Tasca C; Guizzo JA; Conceição FR; Frandoloso R; de Vargas AC
    Vet Microbiol; 2017 Oct; 210():56-63. PubMed ID: 29103697
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Hess JF; George LW
    Vaccine; 2004 Dec; 23(4):537-45. PubMed ID: 15530703
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Infectious bovine keratoconjunctivitis: evidence for genetic modulation of resistance in purebred Hereford cattle.
    Pugh GW; McDonald TJ; Kopecky KE; Kvasnicka WG
    Am J Vet Res; 1986 Apr; 47(4):885-9. PubMed ID: 3516033
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis.
    Hope JC; Thom ML; Villarreal-Ramos B; Vordermeier HM; Hewinson RG; Howard CJ
    Clin Exp Immunol; 2005 Jan; 139(1):48-56. PubMed ID: 15606613
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum antibody response to carbohydrate antigens of Pasteurella haemolytica serotype 1: relation to experimentally induced bovine pneumonic pasteurellosis.
    Confer AW; Simons KR; Panciera RJ; Mort AJ; Mosier DA
    Am J Vet Res; 1989 Jan; 50(1):98-105. PubMed ID: 2465713
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterisation and quantitation of pilus antigens of Moraxella bovis by ELISA.
    Lepper AW; Hermans LR
    Aust Vet J; 1986 Dec; 63(12):401-5. PubMed ID: 2879528
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy of Bdellovibrio bacteriovorus 109J for the treatment of dairy calves with experimentally induced infectious bovine keratoconjunctivitis.
    Boileau MJ; Mani R; Breshears MA; Gilmour M; Taylor JD; Clinkenbeard KD
    Am J Vet Res; 2016 Sep; 77(9):1017-28. PubMed ID: 27580114
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serological characterization of strains of Moraxella bovis using double immunodiffusion.
    Gil-Turnes C; de Araujo FL
    Can J Comp Med; 1982 Apr; 46(2):165-8. PubMed ID: 6178487
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Infectious bovine keratoconjunctivitis: contact transmission.
    Kopecky KE; Pugh GW; McDonald TJ
    Am J Vet Res; 1986 Mar; 47(3):622-4. PubMed ID: 3963562
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antibiotic treatment of Moraxella bovis infection in cattle.
    George LW; Wilson WD; Baggot JD; Mihalyi JE
    J Am Vet Med Assoc; 1984 Nov; 185(10):1206-9. PubMed ID: 6392258
    [No Abstract]   [Full Text] [Related]  

  • 76. Outer membrane protein antigens of Moraxella bovis.
    Ostle AG; Rosenbusch RF
    Am J Vet Res; 1986 Jul; 47(7):1419-21. PubMed ID: 3740610
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intramuscular vaccination of young calves with a Salmonella Dublin metabolic-drift mutant provides superior protection to oral delivery.
    Mizuno T; McLennan M; Trott D
    Vet Res; 2008; 39(3):26. PubMed ID: 18275802
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of Moraxella bovis infections in calves using a long-acting oxytetracycline formulation.
    George LW; Smith JA
    J Vet Pharmacol Ther; 1985 Mar; 8(1):55-61. PubMed ID: 3989901
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Infectious bovine keratoconjunctivitis: an update.
    Miller RB; Fales WH
    Vet Clin North Am Large Anim Pract; 1984 Nov; 6(3):597-608. PubMed ID: 6393547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.